Sativex Versus Placebo When Added to Existing Treatment for Central Neuropathic Pain in MS

Clinical trial NCT00391079 · COMPLETED

Trial details

NCT number: NCT00391079
Sponsor: GW Pharmaceuticals Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2006-09-01
Primary completion: 2008-04-01
Enrollment: 339

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.